Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreren
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepagina
  2. Aandelen
  3. Nederland
  4. Euronext Amsterdam
  5. Pharming Group N.V.
  6. Nieuws
  7. Persberichten
    PHARM   NL0010391025

PHARMING GROUP N.V.

(PHARM)
  Rapport
Real Time Euronext Amsterdam  -  17:35:14 03-02-2023
1.252 EUR   +1.29%
01/02AEX sluit met kleine winst
AM
30/01Techaandelen onderuit in AEX
AM
27/01Signify koploper in groene AEX
AM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Communiquťs de presse de la sociťtť PHARMING GROUP N.V.
18/01Pharming N : Bank of America Corporation - Pharming Group N.V. - Leiden
PU
17/01Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
PU
12/01Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
PU
2022Pharming announces positive interim analysis data from open-label extension study of le..
AQ
2022Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
PU
2022Pharming announces positive interim analysis data from open-label extension study of le..
AQ
2022Pharming announces publication of data from Phase 3 Study of leniolisib in patients wit..
AQ
2022Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
PU
2022Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
PU
2022Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
PU
2022Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
PU
2022Pharming N : Q3 2022 Financial Results Presentation
PU
2022Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
PU
2022Pharming N : Halfjaarlijkse financiële verslaggeving
PU
2022Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
PU
2022Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
PU
2022Pharming N : Group reports financial results for the first half of 2022
PU
2022Pharming N : H1 2022 Financial Results Presentation
PU
2022Pharming N : Pharming Group presenteert tijdens de Jefferies Healthcare Conference
PU
2022Pharming N : Group to present at Jefferies Healthcare Conference 2022
PU
2022Pharming N : Aankondiging publicatie resultaten eerste kwartaal 2022
PU
2022Pharming N : Group Notice of 2021 Full Year Results
PU
2021B. Yanni - Pharming Group N.V. - Leiden
PU
2021M. Pykett - Pharming Group N.V. - Leiden
PU
2021D.A. Jorn - Pharming Group N.V. - Leiden
PU
2021J. van der Meijs - Pharming Group N.V. - Leiden
PU
2021S. Baert - Pharming Group N.V. - Leiden
PU
2021P. Sekhri - Pharming Group N.V. - Leiden
PU
2021L. Kruimer - Pharming Group N.V. - Leiden
PU
2021Pharming Group reports financial results for the first nine months of 2021
PU
2021Pharming N : Pharming Group Notice of 9M Results
PU
2021Pharming N : Group Notice of 9M Results
PU
2021Pharming N : Pharming announces results from clinical trials for the treatment of COVID-19..
PU
2021Pharming N : announces results from clinical trials for the treatment of COVID-19 with RUC..
PU
2021Pharming N : publiceert resultaten van klinische studies naar de behandeling van COVID-19 ..
PU
2021Pharming N : Group reports financial results for the first half of 2021
PU
2021Sign Up Now : Pharming's Half Year Financial Results Webinar
PU
2021Pharming N : signs agreement with NewBridge Pharmaceuticals for the commercialization of R..
PU
2021Pharming N : Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and..
PU
2021Orchard Therapeutics : and Pharming Group Announce Collaboration to Develop and Commercial..
AQ
2021Pharming N : Pharming announces completion of enrolment in Phase II/III study with lenioli..
PU
2021Pharming N : announces completion of enrolment in Phase II/III study with leniolisib for a..
PU
2021Pharming N : Pharming appoints Anurag Relan as Chief Medical Officer and Robert Friesen as..
PU
2021Pharming N : benoemt Anurag Relan tot Chief Medical Officer en Robert Friesen tot Chief Sc..
PU
2021Pharming N : appoints Anurag Relan as Chief Medical Officer and Robert Friesen as Chief Sc..
PU
2021Pharming N : announces the reimbursement of RUCONESTģ in Spain
PU
2021Pharming N : Group to present at Jefferies Virtual Healthcare Conference
PU
2021Pharming N : Group reports financial results for the first quarter of 2021
PU
2021Pharming N : Group presenteert tijdens de 31ste jaarlijkse Oppenheimer Healthcare Conferen..
PU
2021Pharming N : Group presenteert op BioCapital Europe 2021
PU
2021Pharming N : Phishing, Pharming, Malware, And Other Internet Delights
AQ
2021Pharming N : Group, in collaboration with Invitae Corporation, launches genetic testing pr..
PU
2021Pharming N : Group start, in samenwerking met Invitae Corporation, genetisch testprogramma..
PU
2020Pharming N : Group announces ADSs admitted to trade on Nasdaq under the symbol “PHAR..
PU
2020Pharming N : Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq List..
PU
2020Pharming N : Reports on Extraordinary General Meeting of Shareholders
PU
2020Pharming N : announces enrolment of first patient in US clinical trial for the treatment o..
PU
2020Pharming N : Juergen Ernst to retire from Pharming's Board of Supervisory Directors after ..
PU
2020Pharming N : announces commitment to build a new downstream manufacturing facility for RUC..
PU
2020Pharming N : appoints Jeroen Wakkerman as Chief Financial Officer
PU
2020Pharming N : Group reports financial results for the first nine months of 2020
PU
2020Pharming N : convenes Extraordinary General Meeting of shareholders
PU
2020Pharming N : receives Orphan Drug Designation from the European Commission for leniolisib ..
PU
2020Pharming N : announces the publication of data from a compassionate use programme of RUCON..
PU
2020Pharming N : announces enrolment of first patient in multinational clinical trial for the ..
PU
2020Pharming N : Group reports financial results for the first half of 2020
PU
2020Pharming N : Seven Ways to Rob You during COVID-19
AQ
2020Pharming N : reports encouraging results from use of RUCONESTģ in COVID-19 patients
PU
2020Pharming N : Group convenes Annual General Meeting of shareholders
PU
2020Pharming N : Publication of Pharming's 2019 Annual Report
PU
2020Pharming N : CFO to step down
PU
2020Pharming N : Group Reports Strong Preliminary (Unaudited) Financial Results for 2019
PU
2020Pharming N : receives EMA approval of new facility for expansion of RUCONESTģ production
PU
2020Pharming N : announces the placement of Ä125 million senior unsecured convertible bonds du..
PU
2020Pharming N : announces the launch of an offering of approximately Ä125 million senior unse..
PU
1  2  3Volgende
Volgende evenement op PHARMING GROUP N.V.